从指南看糖尿病规范化与个体化治疗的辩证统一.ppt

Endocr Pract. 2013 Mar-Apr;19(2):327-36. AACE comprehensive diabetes management algorithm 2013. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. PMID:[PubMed - in process] The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight Gain 二甲双胍的处方不断上升，磺脲类不断下降，胰岛素控制使用，TDZ初期得到临床认可，但2006-2007证实其心血管风险后出现明显回落 evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies Vasc Health Risk Manag. 2009;5:859-71. Epub 2009 Nov 2. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Meier M, Hummel M. Source Clinic for Hypertension and Nephrology, Hannover, Germany. kfnh_hannover@web.de Initiating oral glucose lowering therapy with metformin in type 2 diabetic patients_an evidence based strategy to reduce the burden of late developing diabetes complications 2010年中国指南的重要更新：2型糖尿病药物治疗的首选药物应是二甲双胍；如果没有二甲双胍的禁忌症，该药物应该一直保留在糖尿病的治疗方案中 * STATEmENT by AN american association of clinical endocrinologists american college of endocrinology consensus panel on type 2 diabetes mellitus_an algorithm for glycemic control Managing Type 2 Diabetes: Going Beyond Glycemic Control J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19. Managing type 2 diabetes: going beyond glycemic control. Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO. Source Northwestern University Medical School, Chicago, IL 60611, USA. markstolar@ dosage Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective Metabolism. 2006 May;55(5 Suppl 1):S2-5. Long-term efficacy of sulfonylureas: a United K